Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF

Publisher： John Wiley & Sons Inc

E-ISSN： 1862-8354|9|7-8|715-731

ISSN： 1862-8346

Source： PROTEOMICS - CLINICAL APPLICATIONS, Vol.9, Iss.7-8, 2015-08, pp. : 715-731

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics

By Liu Yahui   Qing Hong   Deng Yulin  

International Journal of Molecular Sciences, Vol. 15, Iss. 5, 2014-05 ,pp. : 7865-7882

MDPI

Access to resources Recommend Favorite

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 12, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

PENN Biomarker Core of the Alzheimer’s Disease Neuroimaging Initiative

By  

Neurosignals, Vol. 16, Iss. 1, 2007-12 ,pp. : 19-23

Karger

Access to resources Recommend Favorite

Studying macromolecular complex stoichiometries by peptide‐based mass spectrometry

By  

PROTEOMICS, Vol. 15, Iss. 5-6, 2015-03 ,pp. : 862-879

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of novel candidate urinary protein biomarkers for prostate cancer in a multiethnic cohort of South African patients via label‐free mass spectrometry

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 9, Iss. 5-6, 2015-06 ,pp. : 597-609

John Wiley & Sons Inc

Access to resources Recommend Favorite